CAN (BC): EnWave and Aurora Cannabis expand scope of machine delivery to achieve GMP standards

EnWave Corporation reports today that Aurora Cannabis is expanding the scope of requirements for its potential purchase of a third 120kW Radiant Energy Vacuum (“REV™”) machine targeted for its European operations in Denmark. Aurora Nordic Cannabis, a subsidiary of Aurora, plans to develop a pharmaceutical-level GMP facility, which requires several upgrades to the contemplated machinery. "These upgrades will be confirmed as soon as possible and will also increase the economic profile of this prospective equipment purchase," the team with the company explains. 

On April 26, 2019, EnWave and Aurora announced that the companies had entered into a royalty-bearing commercial license agreement with sub-licensing rights, providing Aurora with the exclusive rights to EnWave’s patented REV™ drying technology for the production of cannabis materials in the European Union, excluding Portugal.

Aurora intends to pursue widespread adoption of the REV™ technology throughout its global operations to capture the significant advantages of EnWave’s drying technology when compared to traditional drying methods. 

Benefits of REV™ Technology in the Cannabis Industry
"EnWave’s patented REV™ technology is a rapid, low temperature, continuous drying method that maintains optimal terpene levels, flavour, as well as other product attributes during the drying process," they explain. "The company’s vacuum-microwave technology enables fast, uniform drying with flexible final moisture content; capabilities that are unattainable with freeze drying or air drying."

In the cannabis industry, REV™ technology provides for capital expenditure savings on drying space (smaller footprint) and related HVAC investments, as well as the ability to free up space, which can be repurposed to increase the economic output of each facility. Furthermore, EnWave’s REV™ technology reduces drying time from 5-7 days to less than two hours, resulting in significant working capital savings and speed to market of product. "The technology has certain additional benefits, including the support of industrial-scale flow-through, accelerating the ability for large-scale processing of cannabis and CBD-rich biomass into intermediate or finished product," they conclude. 

For more information:
EnWave
Unit 1 – 1668 Derwent Way
Delta, BC, Canada V3M 6R9
+1.604.806.6110
info@enwave.net 
enwave.net  



Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


© MMJDaily.com 2019

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber